comparemela.com
Home
Live Updates
Urogen Pharma Ltd - Breaking News
Pages:
10
11
12
13
14
15
16
Latest Breaking News On - Urogen pharma ltd - Page 9 : comparemela.com
UroGen Pharma Ltd (URGN) Reports Growth in Q3 Revenue and Progress in Clinical Trials
Net Revenue Rises as Company Advances with UGN-102 Clinical Development
Liz barrett
Clinical development
Urogen pharma ltd
Income statement
Product revenue
Product revenues
E3 2022
Research and development expenses
Net loss
UroGen Pharma Ltd Q3 Loss decreases, beats estimates
UroGen Pharma Ltd. (URGN) revealed Loss for third quarter that decreased from last year and missed the Street estimates. The company's bottom line came in at -$21.
Urogen pharma ltd
Thomson reuters
Urogen pharma
Gen pharma
Analyst estimates
Wall street
Orporate results
Usiness news
Rogen pharma ltd
UroGen Pharma Ltd Q3 Loss decreases, beats estimates
(RTTNews) - UroGen Pharma Ltd. (URGN) revealed Loss for third quarter that decreased from last year and missed the Street estimates. The company.
Urogen pharma ltd
Thomson reuters
Gen pharma
Analyst estimates
UroGen Pharma to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
Conference Call and Webcast Scheduled for Tuesday, November 14, 2023 at 10:00 AM ET .
Urogen pharma ltd
Urogen pharma
Investor relations
Institutional investors own a significant stake of 50% in UroGen Pharma Ltd (NASDAQ:URGN)
Key Insights Institutions' substantial holdings in UroGen Pharma implies that they have significant influence over the.
Elizabeth barrett
Urogen pharma
Menora mivtachim pensions gemel ltd
Urogen pharma ltd
Menora mivtachim pensions
Gemel ltd
Rogen pharma ltd
Nstitutional ownership
vimarsana © 2020. All Rights Reserved.